| Home > Publications Database > Neomento - Towards building a universal solution for virtual reality exposure psychotherapy > print |
| 001 | 145606 | ||
| 005 | 20231212102435.0 | ||
| 024 | 7 | _ | |a 10.1109/CIG.2019.8848110 |2 doi |
| 037 | _ | _ | |a DZNE-2020-00936 |
| 041 | _ | _ | |a English |
| 100 | 1 | _ | |a Streck, Adam |0 P:(DE-2719)2812503 |b 0 |e First author |u dzne |
| 111 | 2 | _ | |a 2019 IEEE Conference on Games (CoG) |c London |d 2019-08-20 - 2019-08-23 |w United Kingdom |
| 245 | _ | _ | |a Neomento - Towards building a universal solution for virtual reality exposure psychotherapy |
| 260 | _ | _ | |c 2019 |
| 336 | 7 | _ | |a Conference Paper |0 33 |2 EndNote |
| 336 | 7 | _ | |a Other |2 DataCite |
| 336 | 7 | _ | |a INPROCEEDINGS |2 BibTeX |
| 336 | 7 | _ | |a conferenceObject |2 DRIVER |
| 336 | 7 | _ | |a LECTURE_SPEECH |2 ORCID |
| 336 | 7 | _ | |a Conference Presentation |b conf |m conf |0 PUB:(DE-HGF)6 |s 1702373031_1340 |2 PUB:(DE-HGF) |x Other |
| 520 | _ | _ | |a We present the neomento project, a solution for virtual reality (VR) exposure therapy (VRET). In our work we have created specific rendering methods and virtual environments (VEs), designed and published a novel form of behavioural control for virtual agents (VA), included biophysiological measurements directly into the experience, and created an asymmetric gameplay system to assure the correct progress of a therapy session. The combination of above allows us to overcome multiple of the limitations that were hindering the previously published VRET solutions. |
| 536 | _ | _ | |a 341 - Molecular Signaling (POF3-341) |0 G:(DE-HGF)POF3-341 |c POF3-341 |f POF III |x 0 |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef Conference |
| 700 | 1 | _ | |a Stepnicka, Philipp |0 P:(DE-2719)2812507 |b 1 |u dzne |
| 700 | 1 | _ | |a Klaubert, Jens |0 P:(DE-2719)2812504 |b 2 |u dzne |
| 700 | 1 | _ | |a Wolbers, Thomas |0 P:(DE-2719)2810583 |b 3 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1109/CIG.2019.8848110 |
| 856 | 4 | _ | |u https://ieeexplore.ieee.org/document/8848110 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/145606/files/DZNE-2020-00936_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/145606/files/DZNE-2020-00936_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:145606 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2812503 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2812507 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812504 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2810583 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-341 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Molecular Signaling |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 1 |
| 914 | 1 | _ | |y 2019 |
| 920 | 1 | _ | |0 I:(DE-2719)1810004 |k AG Schmitz |l Network Dysfunction |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1310002 |k AG Wolbers |l Aging, Cognition and Technology |x 1 |
| 980 | _ | _ | |a conf |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1810004 |
| 980 | _ | _ | |a I:(DE-2719)1310002 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|